<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <latestAction>
      <text>Referred to the House Committee on Energy and Commerce.</text>
      <actionDate>2016-06-08</actionDate>
      <links />
    </latestAction>
    <amendments />
    <billNumber>5414</billNumber>
    <summaries>
      <billSummaries>
        <item>
          <versionCode>00</versionCode>
          <actionDate>2016-06-08</actionDate>
          <actionDesc>Introduced in House</actionDesc>
          <updateDate>2016-06-08T04:00:00Z</updateDate>
          <name>Introduced in House</name>
          <lastSummaryUpdateDate>2016-12-06T16:02:13Z</lastSummaryUpdateDate>
          <text><![CDATA[<p><b>FDA Cross-Center Collaboration Act of 2016</b></p> This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to establish one or more Intercenter Institutes. Each institute must coordinate activities applicable to a major disease area among the FDA centers that review products. Activities may include coordinating staff with relevant expertise, streamlining product review, and enhancing interactions with patients, sponsors, and the biomedical community.]]></text>
        </item>
      </billSummaries>
    </summaries>
    <introducedDate>2016-06-08</introducedDate>
    <calendarNumbers />
    <title>FDA Cross-Center Collaboration Act of 2016</title>
    <notes />
    <policyArea>
      <name>Health</name>
    </policyArea>
    <constitutionalAuthorityStatementText><![CDATA[<pre>[Congressional Record Volume 162, Number 90 (Wednesday, June 8, 2016)]From the Congressional Record Online through the Government Publishing Office [<a href='http://www.gpo.gov'>www.gpo.gov</a>]By Mr. UPTON:H.R. 5414.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8, Clause 1____________________[Page H3564]</pre>]]></constitutionalAuthorityStatementText>
    <updateDate>2018-11-21T21:23:50Z</updateDate>
    <committees>
      <billCommittees>
        <item>
          <systemCode>hsif00</systemCode>
          <type>Standing</type>
          <subcommittees />
          <name>Energy and Commerce Committee</name>
          <chamber>House</chamber>
          <activities>
            <item>
              <name>Referred to</name>
              <date>2016-06-08T14:00:54Z</date>
            </item>
          </activities>
        </item>
      </billCommittees>
    </committees>
    <sponsors>
      <item>
        <fullName>Rep. Upton, Fred [R-MI-6]</fullName>
        <lastName>UPTON</lastName>
        <firstName>FRED</firstName>
        <middleName />
        <party>R</party>
        <bioguideId>U000031</bioguideId>
        <district>6</district>
        <byRequestType />
        <identifiers>
          <gpoId>7991</gpoId>
          <lisID>1177</lisID>
          <bioguideId>U000031</bioguideId>
        </identifiers>
        <state>MI</state>
      </item>
    </sponsors>
    <recordedVotes />
    <titles>
      <item>
        <titleType>Short Titles as Introduced</titleType>
        <chamberName />
        <parentTitleType />
        <chamberCode />
        <title>FDA Cross-Center Collaboration Act of 2016</title>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <chamberName />
        <parentTitleType />
        <chamberCode />
        <title>To amend the Federal Food, Drug, and Cosmetic Act to provide for establishment of one or more Intercenter Institutes within the Food and Drug Administration for a major disease area or areas, and for other purposes.</title>
      </item>
      <item>
        <titleType>Display Title</titleType>
        <chamberName />
        <parentTitleType />
        <chamberCode />
        <title>FDA Cross-Center Collaboration Act of 2016</title>
      </item>
    </titles>
    <billType>HR</billType>
    <version>1.0.0</version>
    <cosponsors>
      <item>
        <lastName>PALLONE</lastName>
        <district>6</district>
        <fullName>Rep. Pallone, Frank, Jr. [D-NJ-6]</fullName>
        <firstName>FRANK</firstName>
        <identifiers>
          <bioguideId>P000034</bioguideId>
          <gpoId>8048</gpoId>
          <lisID>887</lisID>
        </identifiers>
        <sponsorshipWithdrawnDate />
        <middleName />
        <party>D</party>
        <state>NJ</state>
        <bioguideId>P000034</bioguideId>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <sponsorshipDate>2016-06-08</sponsorshipDate>
      </item>
    </cosponsors>
    <createDate>2016-06-09T05:27:07Z</createDate>
    <relatedBills>
      <item>
        <latestTitle>FDA and NIH Workforce Authorities Modernization Act</latestTitle>
        <number>2700</number>
        <latestAction>
          <actionDate>2016-04-18</actionDate>
          <text>Placed on Senate Legislative Calendar under General Orders. Calendar No. 427.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
        <type>S</type>
        <congress>114</congress>
      </item>
      <item>
        <latestTitle>21st Century Cures Act</latestTitle>
        <number>34</number>
        <latestAction>
          <actionDate>2016-12-13</actionDate>
          <text>Became Public Law No: 114-255.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
        <type>HR</type>
        <congress>114</congress>
      </item>
    </relatedBills>
    <laws />
    <cboCostEstimates />
    <congress>114</congress>
    <originChamber>House</originChamber>
    <subjects>
      <billSubjects>
        <policyArea>
          <name>Health</name>
        </policyArea>
        <legislativeSubjects>
          <item>
            <name>Department of Health and Human Services</name>
          </item>
          <item>
            <name>Drug safety, medical device, and laboratory regulation</name>
          </item>
          <item>
            <name>Executive agency funding and structure</name>
          </item>
          <item>
            <name>Food and Drug Administration (FDA)</name>
          </item>
          <item>
            <name>Government employee pay, benefits, personnel management</name>
          </item>
          <item>
            <name>Health promotion and preventive care</name>
          </item>
          <item>
            <name>Medical education</name>
          </item>
        </legislativeSubjects>
      </billSubjects>
    </subjects>
    <actions>
      <actionByCounts>
        <houseOfRepresentatives>3</houseOfRepresentatives>
      </actionByCounts>
      <item>
        <actionDate>2016-06-08</actionDate>
        <actionCode>H11100</actionCode>
        <text>Referred to the House Committee on Energy and Commerce.</text>
        <type>IntroReferral</type>
        <committee>
          <systemCode>hsif00</systemCode>
          <name>Energy and Commerce Committee</name>
        </committee>
        <links />
        <sourceSystem>
          <name>House floor actions</name>
          <code>2</code>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2016-06-08</actionDate>
        <actionCode>Intro-H</actionCode>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <committee />
        <links />
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2016-06-08</actionDate>
        <actionCode>1000</actionCode>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <committee />
        <links />
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
      </item>
      <actionTypeCounts>
        <introducedInHouse>1</introducedInHouse>
        <billReferrals>1</billReferrals>
        <introducedInTheHouse>1</introducedInTheHouse>
      </actionTypeCounts>
    </actions>
    <committeeReports />
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

